Bayesian estimation of HIV-1 dynamics in vivo

Area of Science:

• Virology
• Immunology
• Biostatistics

Background:

• Human immunodeficiency virus type 1 (HIV-1) infection impacts viral dynamics and CD8+ T cell counts.
• Structured treatment interruptions (STIs) are used in HIV-1 management, necessitating accurate modeling of viral dynamics.
• Existing models show considerable variation in parameter estimates for HIV-1 in-host dynamics.

Purpose of the Study:

• To develop and apply a novel statistical model for analyzing viral dynamics in HIV-1 infected patients undergoing STIs.
• To account for treatment efficiency and total CD8+ T cell counts in the modeling of HIV-1 dynamics.
• To estimate key parameters of HIV-1 in-host dynamics with improved accuracy and reduced parameter variability.

Main Methods:

• Utilized a Bayesian approach for parameter estimation using longitudinal data of CD4+ T cell counts, CD8+ T cell counts, and HIV RNA levels.
• Employed spline approximations for modeling CD8+ T cell dynamics, particularly addressing delayed dependence.
• Estimated seven key parameters related to HIV-1 in-host dynamics, treating most as global parameters across patients.

Main Results:

• The novel model successfully estimated parameters for HIV-1 dynamics, showing consistency with previous reports.
• The spline approximation method reduced the number of parameters requiring estimation and handled delayed dependencies effectively.
• New parameters were estimated, supplementing existing knowledge on HIV-1 in-host dynamics. The method demonstrated robustness on simulated data.

Conclusions:

• The developed Bayesian model with spline approximations offers a robust method for analyzing HIV-1 dynamics during STIs.
• The approach provides more reliable parameter estimates, contributing to a better understanding of HIV-1 pathogenesis and treatment response.
• This work enhances current knowledge by estimating novel parameters and validating the methodology on simulated data.